Sichuan Xieli Pharmaceutical Co., Ltd.

As a pioneer biotechnology company founded in 1992, Xieli has now grown into a ￥112 million corporation by clearly focusing on the goal of providing the best plant-derived pharmaceutical materials around the globe. As a joint-venture corporation, it is comprised of Sichuan Xieli Pharmaceutical Co., Ltd and Sichuan Jian-jiang Pharmaceutical Co., Ltd., which locate in the Sichuan Province, South of China and consists of 3 production sites occupies 150,000 square meters and 1 plantation with a staff of more than 500 people.                 With the abundant natural plant resources in China, we provide the best-qualified products including pharmaceutical intermediates, bioactive materials and botanical drug products alone with professional technical support Our products cover a large range of plant extracted raw materials such as Rutin, Troxerutin, Soy Isoflavones, Hesperidin, Diosmin, Quercetin, Artemisinin, Paclitaxel and Camptothecin, 10-hydroxy-CPT, 7-ethyl-10-hydroxy-CPT, Irinotecan, Topotecan, etc. We also produce herbal drug formulations including Venoruton, Dexamethasone Acetate, Metronidazole, Ibuprofen and several others. The manufacture process of Xieli is strictly complied with GMP guidelines and all of the products meet or exceed Pharmacopoeias such as USP、BP、JP and EP. One of our main products, Rutin is in the process to apply for COS of Rutin by EDQM. Keeping up with the modern technologies, Xieli is always trying to create top services for our clients. We has the world-top extraction facilities and adopt many advanced testing equipments such as HPLC, UV detector and IR analyzer to ensure the perfect qualities of our products. Our strong R&D group consists 21 senior engineers including 1 professor, 3 Ph.D. and 6 masters and the team is collaborating with the Chengdu Institute of Biology, Chinese Academy of Sciences (CIB, CAS), which allows us to design and to develop products according to the desire of our customers.  [ Click for details ]